These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27997963)

  • 1. Efficacy of the CryoBalloon Focal Ablation System for the eradication of dysplastic Barrett's esophagus islands.
    Künzli HT; Schölvinck DW; Meijer SL; Seldenrijk KA; Bergman JGHM; Weusten BLAM
    Endoscopy; 2017 Feb; 49(2):169-175. PubMed ID: 27997963
    [No Abstract]   [Full Text] [Related]  

  • 2. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett's esophagus (with video).
    Canto MI; Shaheen NJ; Almario JA; Voltaggio L; Montgomery E; Lightdale CJ
    Gastrointest Endosc; 2018 Sep; 88(3):438-446.e2. PubMed ID: 29626424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective.
    Sengupta N; Ketwaroo GA; Bak DM; Kedar V; Chuttani R; Berzin TM; Sawhney MS; Pleskow DK
    Gastrointest Endosc; 2015 Sep; 82(3):443-8. PubMed ID: 25887715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal Cryoballoon Ablation for Eradication of Barrett's Esophagus-Related Neoplasia: A Prospective Multicenter Clinical Trial.
    Canto MI; Trindade AJ; Abrams J; Rosenblum M; Dumot J; Chak A; Iyer P; Diehl D; Khara HS; Corbett FS; McKinley M; Shin EJ; Waxman I; Infantolino A; Tofani C; Samarasena J; Chang K; Wang B; Goldblum J; Voltaggio L; Montgomery E; Lightdale CJ; Shaheen NJ
    Am J Gastroenterol; 2020 Nov; 115(11):1879-1890. PubMed ID: 33156107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic ablation of Barrett's neoplasia with a new focal radiofrequency device: initial experience with the Halo60.
    Allen B; Kapoor N; Willert R; McEwan H; Fullarton G; Penman I
    Endoscopy; 2012 Jul; 44(7):707-10. PubMed ID: 22723187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of a primary complete endoscopic resection strategy for short-segment Barrett's esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma.
    Bahin FF; Jayanna M; Hourigan LF; Lord RV; Whiteman D; Williams SJ; Lee EY; Bourke MJ
    Gastrointest Endosc; 2016 Jan; 83(1):68-77. PubMed ID: 26096759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid nitrogen spray cryotherapy for eradication of dysplastic Barrett's esophagus: results from a multicenter prospective registry.
    Eluri S; Cotton CC; Kaul V; McKinley M; Pleskow D; Nishioka N; Hoffman B; Nieto J; Tsai F; Coyle W; Kothari S; Joshi V; Dumot J; Greenwald B; Habr FG; Shaheen NJ
    Gastrointest Endosc; 2024 Aug; 100(2):200-209. PubMed ID: 38272279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-session endoscopic resection and focal radiofrequency ablation for short-segment Barrett's esophagus with early neoplasia.
    Barret M; Belghazi K; Weusten BL; Bergman JJ; Pouw RE
    Gastrointest Endosc; 2016 Jul; 84(1):29-36. PubMed ID: 26769410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus.
    Canto MI; Shin EJ; Khashab MA; Molena D; Okolo P; Montgomery E; Pasricha P
    Endoscopy; 2015 Jul; 47(7):582-91. PubMed ID: 25826275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Barrett's esophagus with a novel focal cryoablation device: a safety and feasibility study.
    Schölvinck DW; Künzli HT; Kestens C; Siersema PD; Vleggaar FP; Canto MI; Cosby H; Abrams JA; Lightdale CJ; Tejeda-Ramirez E; DeMeester SR; Greene CL; Jobe BA; Peters J; Bergman JJ; Weusten BL
    Endoscopy; 2015 Dec; 47(12):1106-12. PubMed ID: 26158241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients.
    Dumot JA; Vargo JJ; Falk GW; Frey L; Lopez R; Rice TW
    Gastrointest Endosc; 2009 Oct; 70(4):635-44. PubMed ID: 19559428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrous oxide cryotherapy for treatment of esophageal squamous cell neoplasia: initial multicenter international experience with a novel portable cryoballoon ablation system (with video).
    Canto MI; Abrams JA; Künzli HT; Weusten B; Komatsu Y; Jobe BA; Lightdale CJ
    Gastrointest Endosc; 2018 Feb; 87(2):574-581. PubMed ID: 28720474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett's esophagus.
    Künzli HT; Schölvinck DW; Phoa KN; Schoon EJ; Houben MH; Bergman JJ; Weusten BL
    Endoscopy; 2015 Jul; 47(7):592-7. PubMed ID: 25675174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult adenocarcinoma after esophagectomy for Barrett's high-grade dysplasia.
    Donnellan F; Harewood GC; Patchett SE
    Gastrointest Endosc; 2010 Feb; 71(2):429. PubMed ID: 20152322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.